GLOMERULAR TIP LESION (GTL) IS NOT ONLY STRUCTURALLY BUT ALSO CLINICALLY DISTINCT FROM OTHER TYPES OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)

被引:0
|
作者
MILLING, DM [1 ]
IWILKMAN, AS [1 ]
FALK, RJ [1 ]
JENNETTE, JC [1 ]
机构
[1] UNIV N CAROLINA,CHAPEL HILL,NC 27514
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:837 / 837
页数:1
相关论文
共 13 条
  • [1] Glomerular tip lesion (GTL): Clinical features, response to corticosteroids and comparison to focal segmental glomerulosclerosis (FSGS).
    HoganMoulton, AE
    Hogan, SL
    Falk, RJ
    Jennette, JC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0418 - A0418
  • [2] Increased body weight and increased glomerular size are associated with focal segmental glomerulosclerosis (FSGS) but not with glomerular tip lesion (GTL).
    Taylor, JG
    Hogan, S
    Falk, RJ
    Jennette, JC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2502 - A2502
  • [3] Mycophenolate mofftil (MMF) as a first line agent in the treatment of the glomerular tip lesion of focal segmental glomerulosclerosis (FSGS)
    Varvarelis, Nicholas
    Snyder, Richard
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : A93 - A93
  • [4] Glomerular tip lesion: A distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum
    Stokes, MB
    Markowitz, GS
    Lin, J
    Valeri, AM
    D'Agati, VD
    KIDNEY INTERNATIONAL, 2004, 65 (05) : 1690 - 1702
  • [5] Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion
    Howie, AJ
    Pankhurst, T
    Sarioglu, S
    Turhan, N
    Adu, D
    KIDNEY INTERNATIONAL, 2005, 67 (03) : 987 - 1001
  • [6] Tip Lesion Variant of Focal and Segmental Glomerulosclerosis (FSGS): A Case Report in a Patient with COVID-19
    Afonso, Rita S.
    Cabrita, Ana
    Silva, Ana P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 91 - 91
  • [7] Complete remission of tip lesion variant focal segmental glomerulosclerosis (FSGS) with the Janus Kinase (JAK) inhibitor tofacitinib
    Martin Sedlacek
    Jason R. Pettus
    CEN Case Reports, 2022, 11 : 225 - 230
  • [8] Complete remission of tip lesion variant focal segmental glomerulosclerosis (FSGS) with the Janus Kinase (JAK) inhibitor tofacitinib
    Sedlacek, Martin
    Pettus, Jason R.
    CEN CASE REPORTS, 2022, 11 (02) : 225 - 230
  • [9] Non-glomerular Tip Lesion Focal Segmental Glomerulosclerosis as a Negative Predictor in Idiopathic Membranous Nephropathy
    Wang, Hui
    Wan, Cheng
    Jiang, Man
    Zhang, Chun
    CURRENT MEDICAL SCIENCE, 2022, 42 (05) : 1007 - 1014
  • [10] Non-glomerular Tip Lesion Focal Segmental Glomerulosclerosis as a Negative Predictor in Idiopathic Membranous Nephropathy
    Hui Wang
    Cheng Wan
    Man Jiang
    Chun Zhang
    Current Medical Science, 2022, 42 : 1007 - 1014